MeDiNova Research is Other Healthcare Services in United Kingdom that focus on clinical research services business. Founded in 1997. They cover business area such as investigator, Coventry, England, research site, specialize, Phase II-IV clinical study, multiple therapeutic area, client expectation, their delivery programme, their participation.
1997
( 27 years old in 2024 )
Clinical Research Services
-
Friars House
Manor House Drive
Coventry CV1 2TE
England, United Kingdom
Private
investigatorCoventryEnglandresearch sitespecializePhase II-IV clinical studymultiple therapeutic areaclient expectationtheir delivery programmetheir participation
* We use standard office opening hours in near MeDiNova Research's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
MeDiNova Research is Other Healthcare Services business from United Kingdom that founded in 1997 (27 years old in 2024), MeDiNova Research business is focusing on Clinical Research Services.
MeDiNova Research headquarter office and corporate office address is located in Friars House Manor House Drive Coventry CV1 2TE England, United Kingdom.
MeDiNova Research was founded in United Kingdom.
In 2024, MeDiNova Research is currently focus on clinical research services sector.
Above is snippet of Google Trends for "clinical research services" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with MeDiNova Research, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
